- In recent weeks, Salesforce has expanded its enterprise AI footprint, highlighted by the U.S. Army Human Resources Command selecting Agentforce for secure, autonomous HR support within an IL5-authorized environment and by leadership changes including Srini Tallapragada stepping down to a Special Advisor role.
- Together with Agentforce’s very large ARR growth and upcoming high-profile AI keynotes, these developments underscore Salesforce’s push to embed agentic AI deeply into mission-critical public and private sector workloads.
- We’ll now examine how the U.S. Army’s Agentforce deployment could reshape Salesforce’s investment narrative around enterprise AI adoption.
We've uncovered the 11 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
Salesforce Investment Narrative Recap
To own Salesforce today, you need to believe its pivot to deeply embedded, secure agentic AI can offset maturing core CRM and support durable, profitable growth. In the near term, Agentforce’s ARR surge and marquee government deployments are a key catalyst, while the biggest risk is whether AI usage and new pricing models can truly replace the traditional seat based engine. The recent U.S. Army win reinforces the AI story but does not remove that pricing and monetization risk.
The U.S. Army Human Resources Command’s decision to run Agentforce in an IL5 authorized environment stands out as the most relevant development here. It showcases Salesforce’s ability to handle highly sensitive, high volume workflows with autonomous agents, directly tied to its core AI monetization catalyst. At the same time, Srini Tallapragada’s transition to a Special Advisor role keeps some continuity across product, engineering, and large customer programs during this critical AI expansion phase.
Yet beneath the Agentforce momentum, investors should be aware that Salesforce’s high debt load and evolving AI driven pricing could...
Read the full narrative on Salesforce (it's free!)
Salesforce's narrative projects $56.7 billion revenue and $10.3 billion earnings by 2029. This requires 9.8% yearly revenue growth and about a $2.3 billion earnings increase from $8.0 billion today.
Uncover how Salesforce's forecasts yield a $241.72 fair value, a 17% upside to its current price.
Exploring Other Perspectives
Some of the lowest estimate analysts were assuming Salesforce’s revenue would grow only about 8.2 percent a year with margins compressing to roughly 14.6 percent, which is far more cautious than the AI acceleration story and raises fair questions about whether deals like the U.S. Army Agentforce rollout ultimately support the optimistic or the pessimistic camp over time.
Explore 23 other fair value estimates on Salesforce - why the stock might be worth just $241.65!
Form Your Own Verdict
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
- A great starting point for your Salesforce research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.
- Our free Salesforce research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Salesforce's overall financial health at a glance.
Seeking Other Investments?
The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:
- AI is about to change healthcare. These 42 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
- The future of work is here. Discover the 37 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
- This technology could replace computers: discover 24 stocks that are working to make quantum computing a reality.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com